8-KThe WireStrategic
Results of Operations
Filed May 7, 2026 · 1mo ago · Accession 0001628280-26-032093
Plain English
Ginkgo Bioworks Holdings, Inc. reported its first quarter 2026 financial results, which included a decrease in revenue and a net loss from continuing operations. The company also announced the completion of its Biosecurity business divestiture.
Filing details
- Ticker
- DNA
- CIK
- 1830214
- Form type
- 8-K
- Filing date
- May 7, 2026
- Report date
- May 7, 2026
- Document
- dna-20260507.htm
- Size
- 361 KB